Reply to ‘A phase II randomized controlled trial of nicotinamide for skin cancer chemoprevention in renal transplant recipients’

2017 ◽  
Vol 176 (2) ◽  
pp. 551-552 ◽  
Author(s):  
O. Yélamos ◽  
A.C. Halpern ◽  
M.A. Weinstock
Sign in / Sign up

Export Citation Format

Share Document